Medicine powerfully mediates the relationship between life and death. This article argues that in the name of health, modern medicine constitutes a pathological mortal subjectivity, encouraging individuals to experience death as disease, to understand mortality as morbidity, and to approach living instrumentally as a means to longevity. This article uses the example of hypertension management to illustrate how this vision of death is transformed into a form of life.Through the analysis of a number of disciplinary technologies — from technical definitions of health to blood pressure monitoring — it illustrates how individuals are incited to relate to death in an antagonistic, impersonal, and technical fashion. While contemporary forms of capital accumulation in the health field require an intensification of such relations, this article suggests that there much to be gained from exploring visions of health that are not at odds with death.
AHA (2005a). High blood pressure in children. American Heart Association. from http://www.americanheart.org/presenter.jhtml?identifier=4609 (accessed March 20 2006).
2.
AHA (2005b). Supportive spouse may reduce effect of job strain on blood pressure. American Heart Association. http://www.amhrt.org/presenter.jhtml?identifier=3033808 (accessed October 22 2005).
3.
Ariès, P. (1981). The hour of our death (H. Weaver, Trans.). New York: Vintage.
4.
Armstrong, D. (1987). Silence and truth in death and dying. Social Science and Medicine, 24(8), 651—7.
5.
Armstrong, D. (1993). Medical surveillance of normal populations. In G. Lawrence (Ed.), Technologies of modern medicine, pp. 73—80. London: Science Museum.
6.
Armstrong, D. (1995). The rise of surveillance medicine. Sociology of Health and Illness, 17(3), 393—404.
7.
Banerjee, A. (2005). `Speaking of death'. Interculture,2(2). http://www.fsu.edu/~proghum/interculture/vol2.html
8.
Banerjee, A. (2006). `Living and dying through the technologies of biomedicine and meditation', paper presented to CSAA Congress, Toronto, Canada.
9.
Bauman, Z. (1992). Mortality, immortality, and other life strategies . Cambridge: Polity Press.
10.
Bauman, Z. (1993a). Scandal of death. New Statesman and Society, 6 (248), 21.
11.
Bauman, Z. (1993b). Postmodern ethics. Oxford : Blackwell.
12.
Bcma (1991). High blood pressure: The silent killer. Vancouver: The British Columbia Medical Association (BCMA).
13.
Byock, I. (1997). Dying well. New York: RiverHead Books.
14.
Canada A.M. (1999). High blood pressure victims urged to take their medication, June 9. Toronto: CTV .
15.
Callahan, D. (1998). False hopes. New York: Simon and Schuster.
16.
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A. and Izzo, J.L. et al. (2003). The JNC report. JAMA, 289(19), 2560—72.
17.
Clarke, A.E., Shim, J.K., Mamo, L., Fosket, J.R. and Fisherman, J.R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and US biomedicine. American Sociological Review, 68(2), 161—93.
18.
Conrad, P. (2005). The shifting engines of medicalization. Journal of Health and Social Behavior, 46(1), 3—14.
19.
Crawford, R. (1980). Healthism and the medicalization of everyday life . International Journal of Health Services, 10(3), 365—388.
20.
Crawford, R. (2004). Risk ritual and the management of control and anxiety in medical culture. Health: An InterdisciplinaryJournal for the Study of Health, Illness and Medicine, 8(4), 505—28. London: Sage.
21.
Douma, A. (1998). Man's blood pressure rises in morning. Montreal Gazette, p. B7.
22.
ESH and ESC (2003). `2003 guidelines for the management of arterial hypertension': Journal of Hypertension, 21, 1011—1053.
23.
Feldman, R.D., Campbell, N., Larochelle, P., Bolli, P., Burgess, E.D. and Carruthers, G., et al. (1999). 1999 Canadian recommendations for the management of hypertension. CMAJ, 161(12 Suppl): S1—17.
24.
Fields, L.E., Burt, V.L., Cutler, J.A., Hughes, J., Rocella, E.J. and Sorlie, P. (2004). The burden of adult hypertension in the United States: 1999 to 2000. Hypertension, 44, 1—7.
25.
Foucault, M. (1973). The birth of the clinic (A.M.S. Smith, Trans.) . New York: Vintage Books.
26.
Foucault, M. (1977). Discipline and punish (A. Sheridan, Trans.). New York: Vintage Books.
27.
Frost & Sullivan (2006). ` Blood pressure montoring markets: new technologies determine new milestones '. Accessed January 16, 2007 from: http://www.healthcare.frost.com.
28.
Gregoire, J.R. (1998). Update on the management of hypertension. Cardiovascular Reviews & Reports,19(26), 29.
29.
Health Canada (2000). National high blood pressure prevention and control strategy. Ottawa : Health Canada and the Canadian Coalition for High Blood Pressure Prevention and Control.
30.
Heart and Stroke Foundation (2005). Heart and stroke foundation calls for faster, earlier, more aggressive treatment of high BP. Toronto: Heart and Stroke Foundation.
31.
Hockey, E.L. (1990). Experiences of death. Edinburgh : Edinburgh University Press.
32.
Illich, I. (1976). Limits to medicine. Toronto : McClelland and Stewart LTD.
33.
IMS (2003). IMS reports 8 percent constant dollar growth in 2002 audited global pharmaceutical sales to $400.6 Billion. http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_41336931,00.html . (accessed December 8 2005).
34.
IMS (2006a). IMS drug monitor: Canada, leading diagnoses, 2004. http://www.imshealthcanada.com/htmen/3_2_18.htm (accessed March 28 2006).
35.
IMS. (2006b). A health information update from IMS health: Hypertension. http://www.imshealthcanada.com/htmen/3_1_32.htm (accessed March 20 2006).
36.
JNC (2004). The seventh report of the joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Washington, DC: US Department and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program .
37.
Joffres, M.R., Ghadirian, P., Fodor, J.G., Petrasovits, A., Chockalingam, A. and Hamet, P. (1997). Awareness, treatment and control of hypertension in Canada. American Journal ofHypertension, 10(10), 1097—1102.
38.
Kawachi, I. and Conrad, P. (1996). Medicalization and high blood pressure. In P. Davis (Ed.), Contested ground, pp. 26—41. Oxford: Oxford University Press.
39.
Le Fanu, J. (1999). The rise and fall of modern medicine. New York: Carroll and Graf Publishers.
40.
Lloyd, A., Schmieder, C. and Marchant, N. (2003). Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics, 21(Suppl 1), 33—41.
41.
Lock, M. (2002). Twice dead. Berkeley, CA: University of California Press.
42.
Lopez, A., Mathers, C., Ezzati, M., Jamison, D., and Murray, C. (2006). `Global and regional burden of disease and risk factors, 2001. The Lancet,367 (9524), 1747—57.
43.
Moynihan, R. and Cassels, A. (2005). Selling sickness. Vancouver : Greystone Books.
44.
Mulrow, P.J. (1999). Hypertension: A worldwide epidemic. In J.L. Izzo and H.R. Black (Eds.), Hypertension primer, 2nd Edition, pp. 271—5. Baltimore, MD: Williams and Wilkins.
45.
Mykhalovskiy, E. and Weir, L. (2004). The problem of evidence-based medicine: Directions for social science. Social Science and Medicine, 59, 1059—69.
46.
NIH and NHLBI (1994). High blood pressure. National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute (NHLBI).
47.
Orum, S. and Heinemann, W. (1971). Clinical Heart Disease. London : Medical Books Ltd.
48.
Petrella, R.J. and Campbell, N.R. (2005). Awareness and misconception of hypertension in Canada. Canadian Journal ofCardiology, 21(7), 589—93.
49.
Pfizer (2005). 2005annual review. http://www.pfizer.com/pfizer/annualreport/2005/annual/review2005.pdf (accessed Feb 14 2006).
50.
Postel-Vinay, N. (1996). A century of hypertension: 1896—1996. Chichester: J. Wiley.
51.
Prior, L. (1984). The rationalization of death. Theory, Culture and Society, 2(2), 55—70.
52.
Prior, L. (1989). The social organization of death. London: Macmillan.
53.
Raphael, D. (2002). Social justice is good for our hearts. Toronto: CSJ Foundation for Research and Education.
54.
Rudd, P. (2000). Medication compliance for antihypertensive therapy . In S. Oparil (Ed.), Hypertension , pp. 419—31. Philadelphia, PA: W.B. Saunders.
55.
Swales, J.D. (1985). Platt versus Pickering. London : Keynes Press.
56.
Thomas, J.T. and Rocella, E.J. (1999). Trends in blood pressure control and mortality . In J.L. Izzo and H.R. Black (Eds.), Hypertension primer , 2nd edition, pp. 268—70. Baltimore, MD: Williams and Wilkins.
57.
Weber, M. (1904/2001). The protestant ethic and the spirit of capitalism. (T. Parsons, Trans.). New York: Routledge.
58.
WHO (1999). Guidelines set new definitions. International Journal of Public Health, 77(3), 293.
59.
WHO (2002). The world health report 2002. Geneva: World Health Organization.
